The BELLA Programme uses cookies to deliver the best possible web experience.

By continuing to use this site, you agree that we may store and access cookies on your device. Please ensure you have read the Cookies Policy. Learn more

I understand
Bioinformatics and AI Testbed
Platform-as-a-Service for Assisted Discovery of Molecular Interaction Networks.

Cellular functioning (genetic regulation, metabolism, cellular signaling, and the immune system, among others) is composed of networks of molecular interaction and regulation. Understanding these systems forms the basis for the development of targeted therapies, personalized medicine, and advances in biotechnology. Each system requires a large amount of theoretical and practical experimentation, whose integration is impossible without analytical methods capable of combining vast amounts of scientific information dispersed across multiple repositories.

This architecture enables the identification of molecular interaction networks; the modeling of "what-if" scenarios based on scientific knowledge before committing resources to costly experiments; the development of preliminary models that reduce risks in early research phases; and experimentation with an AI-based methodology adaptable to the research scenario of interest. Additionally, the platform ensures reproducibility through complete traceability of each result, allowing studies to be replicated with different search parameters to facilitate systematic hypothesis exploration.

Key Features

Transparent and Traceable Reasoning

Each molecular relationship includes specific scientific references and inference logic that can be verified by the researcher.

Automatic Source Integration

Automatically connects to PubMed, PubTator, Protein Data Bank, HGNC, Gene Ontology, and other specialized repositories to organize and maintain up-to-date knowledge bases.

Expert Process Control

The researcher defines search parameters, validates results, and refines models according to their specialized domain knowledge.

Experimental Hypothesis Generation

Identifies specific regulatory pathways and candidate subnetworks to guide laboratory experimental decisions.


Use of Generative and Logical AI

Accesses generative AI models to model molecular interactions and uses logical AI to model and infer molecular interaction pathways and subnetworks.



Interested in using the BELLA II Bioinformatic testbed?

Take advantage of advanced and flexible environments to develop, test, and optimize applications and technologies that require High-Performance Computing.

Make your inquiry.

Uses

Alt Text

Disease Mechanism Analysis

Develop network models to understand molecular interactions in complex pathologies such as cancer or neurological disorders.

Alt Text

Therapeutic Target Modeling

Build specific regulatory networks to identify candidate proteins and molecular pathways for drug development.

Alt Text

Therapeutic Strategy Design

Computationally explore transitions between pathological and healthy states to identify potential interventions.

Alt Text

Exploration of Scientific Hypotheses

Use predictive models to identify expert knowledge on hypothetical pathways and interactions, assisting in the design of laboratory experiments.

Alt Text

Generative AI models

Learn how to train generative AI models for your application domain and how to interact with logical AI to guide the discovery processes of your molecular interaction pathways and subnetworks.

More Information

  • Customization and Adaptability
    Researchers can define specific objects of interest (genes, proteins, drugs), adjust search parameters, and retrain models for particular domains. The platform retrieves information from specialized repositories and incorporates domain-specific ontologies.
  • Service Model
    We provide access to the platform, training in our methodology, use of our tools, and continuous technical support. Researchers maintain full control over their data and generated models.
  • Validation and Use Cases
    The platform has been used to model genetic regulatory networks in COVID-19, identifying correlations such as ACE2-COVID-19 with full bibliographic validation. Each result includes PubMed identifiers for independent verification.
  • Visit: https://github.com/biopatternsg/biopatternsg

ACKNOWLEDGEMENTS

BELLA II receives funding from the European Union through the Neighbourhood, Development and International Cooperation Instrument (NDICI), under agreement number 438-964 with DG-INTPA, signed in December 2022. The implementation period of BELLA II is 48 months.

Contact

For more information about BELLA II please contact:

redclara_comunica@redclara.net

© Copyright 2017 . All Rights Reserved